Evidence map›Paper›PMID 40016615›Full record

ArticleAnnals of surgical oncology2025

Gait Speed as a Measure of Frailty and Outcomes After Lung Resection.

Anupama Singh, Yue Xie, Emanuele Mazzola, Sue Wang, Miles McAllister, Fatemehsadat Pezeshkian, Lisa Cooper, Laura N Frain, Fatima G Wilder, Desiree Steimer and 2 more

Abstract read
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Preoperative albumin grip index as a novel biomarker predicting prognosis and postoperative complications after gastrectomy for gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anupama SinghDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA. anupamasingh0312@gmail.com.ORCID http://orcid.org/0000-0001-7776-4584
Yue XieDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
Emanuele MazzolaDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
Sue WangDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Miles McAllisterDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Fatemehsadat PezeshkianDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Lisa CooperRabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.
Laura N FrainDivision of Aging, Brigham and Women's Hospital, Boston, MA, USA.
Fatima G WilderDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Desiree SteimerDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Michael T JaklitschDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Clark DuMontierDivision of Aging, Brigham and Women's Hospital, Boston, MA, USA.

Funding

CSRD VA IK2 CX002218
6 · The paper itself

Abstract

backgroundAs a powerful, objective marker of frailty, 4-m gait speed (4MGS) can predict morbidity and mortality in various populations including cardiac surgery and oncology patients. Its role in thoracic surgery is understudied. This study aimed to evaluate associations between preoperative 4MGS and outcomes after pulmonary resection.

methodsA cohort study analyzed patients undergoing pulmonary resections at a high-volume surgical center from January 2021 to October 2023. Preoperative 4MGS was prospectively collected by medical assistants as part of routine vital sign assessments in clinic. Uni- and multivariable analyses were performed to evaluate the associations of preoperative 4MGS with postoperative length of stay, adverse events, and discharge disposition, controlling for lung function (FEV1), extent of resection, comorbidity, and other covariates.

resultsOverall, 401 patients were included (median age, 69 years; interquartile range, 61-75 years): 123 (31%) lobectomy and 278 (69%) sublobar resection patients. After controlling for covariates, each decrease of 0.1 m/s in 4MGS was associated with average longer length of stay (beta, 0.12; 95% confidence interval [CI], 0.01-0.23) and increased odds of adverse events (odds ratio [OR], 1.10; 95% CI 1.00-1.25). These associations were largely maintained when analyses were repeated within the lobar and sublobar cohorts. Among the sublobar resections, decreases in 0.1 m/s of 4MGS was associated with increased odds of discharge to home requiring home services or to a rehabilitation facility (OR, 1.10; 95% CI 1.00-1.22).

conclusionsPreoperative 4MGS is independently associated with important surgical outcomes after lung resection. The 4MGS marker can complement other preoperative measures used to risk-stratify patients undergoing lung resection.

Indexed as

FrailtyLung NeoplasmsPneumonectomyPostoperative ComplicationsWalking SpeedAgedFemaleFollow-Up StudiesHumansLength of StayMaleMiddle AgedPrognosisProspective Studies

Identifiers

PMID40016615
PMCPMC12857551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.